Sagan Pharma Private Limited
About Sagan Pharma Private Limited
Data last updated:
Sagan Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 13 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC281048. Its GSTIN is 27AAXCS1242A1ZF (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Sagan Pharmacy Private Limited. It is led by directors Amarnath Kumar and Smriti Manjari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 179 Dreams The Mall Lbs Marg Bhandup (W), Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹1.95 Lakh (net margin 1.5%) and EBITDA of ₹3.35 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressF – 179 Dreams The Mall Lbs Marg Bhandup (W), Mumbai, Maharashtra, India – 400078
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sagan Pharma Private Limited
The main business activity of Sagan Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sagan Pharma Private Limited FY 2025 filings available
Sagan Pharma Private Limited reported revenue of ₹1.31 Cr (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sagan Pharma Private Limited
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sagan Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.95 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sagan Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sagan Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sagan Pharma Private Limited
Sagan Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrirampur Super Speciality Hospital Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Shrirampur, Maharashtra, India |
| Lasya Health Private Limited | ₹1.32 Cr (FY 2021) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Preeti Medical Centre (India) Private Limited | ₹1.32 Cr (FY 2022) | •••• | •••• | 33.0% | •••• | Mumbai, Maharashtra, India |
| Arel Hope Recovery Services Private Limited | ₹1.32 Cr (FY 2023) | •••• | •••• | 14.0% | •••• | Khairatabad, Telangana, India |
| MJM Italia Healthcare Private Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 95.0% | •••• | Jhansi, Uttar Pradesh, India |
| Sagan Pharma Private Limited this company | ₹1.31 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Adayu Mindfulness Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 5915.0% | •••• | New Delhi, Delhi, India |
| Medamrit Healthcare Services Private Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 191.0% | •••• | Mumbai, Maharashtra, India |
| Mediconnect Respiratory Solution Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | 113.0% | •••• | Delhi, India |
| Ayursundra Diagnostics Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | -40.0% | •••• | Gmc, Assam, India |
| Dev Desai Fitness (OPC) Private Limited | ₹1.3 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Sagan Pharma by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sagan Pharma Private Limited
Sagan Pharma Private Limited is audited by AMIT GAGANDAS BAJAJ & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT GAGANDAS BAJAJ & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sagan Pharma Private Limited
Sagan Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smriti Manjari Also directs: Sagan Media Private Limited, Wrap Data Private Limited, Sagan Aangels Private Limited and 1 more | Additional Director | 08 May 2023 | 3 Years 5 Months | Current |
| Amarnath Kumar Also directs: Sagan Media Private Limited, Wrap Data Private Limited, Kavrin Events Private Limited and 1 more | Director | 13 May 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Sagan Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sagan Pharma Private Limited
Sagan Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sagan Pharma Private Limited
Employment history and EPFO contributions of people linked to Sagan Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sagan Pharma Private Limited
Sagan Pharma Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Tumpa Dibyendu Chowdhury ceased to be Director on 28 Jun 2024.
Credit Ratings, Litigation & Regulatory Alerts for Sagan Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sagan Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sagan Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sagan Pharma Private Limited
Sagan Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS1242A1ZF | Maharashtra | Active | 01 Jul 2020 |
| 19AAXCS1242A1ZC | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sagan Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagan Pharma Private Limited
Sagan Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 13 May 2016 (10+ years old) and is registered under CIN U74999MH2016PTC281048.
Sagan Pharma reported revenue of ₹1.31 Cr for FY 2025 (down 18% YoY).
Sagan Pharma has 2 current directors:
- Smriti Manjari - Additional Director
- Amarnath Kumar - Director
Sagan Pharma reported a net profit of ₹1.95 Lakh (net margin 1.5%) and EBITDA of ₹3.35 Lakh (EBITDA margin 2.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sagan Pharma is 15% over three years and 18% over five years. In the latest year (FY 2025) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sagan Pharma is 27AAXCS1242A1ZF, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AAXCS1242A1ZC (West Bengal).
The CIN (Corporate Identification Number) of Sagan Pharma is U74999MH2016PTC281048. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sagan Pharma was incorporated on 13 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sagan Pharma by revenue are Shrirampur Super Speciality Hospital Private Limited, Lasya Health Private Limited, Preeti Medical Centre (India) Private Limited, Arel Hope Recovery Services Private Limited, MJM Italia Healthcare Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Tumpa Dibyendu Chowdhury ceased to be Director on 28 Jun 2024. Smriti Manjari was appointed as Additional Director on 08 May 2023. Susim Sahabal Yadav ceased to be Director on 08 May 2023. Sagan Pharma has 4 board changes on record in total.
The registered office of Sagan Pharma is at F – 179 Dreams The Mall Lbs Marg Bhandup W, Mumbai, Maharashtra, India – 400078.